Startup India Government of India
Cure Plus Biosciences Private Limited - healthcare in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.79 Cr
▲ 67% YoY
Net profit · FY 2024
₹6.83 Lakh
Net margin 2.4%
EBITDA · FY 2024
₹21.31 Lakh
EBITDA margin 7.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹14 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Cure Plus Biosciences Private Limited
Data last updated:
Cure Plus Biosciences Private Limited is a private limited company based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 30 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2020PTC191589.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sulbha Laxman Hingane and Chetan Purushotam Wadgure.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. B – 1004 Balaji Mesmero Sr.No – 283/3 4/2/A Porwal Road Lohegaon, Pune, Maharashtra, India – 411047.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.79 Cr, a growth of 67% compared to the previous year. For the same year it recorded a net profit of ₹6.83 Lakh (net margin 2.4%) and EBITDA of ₹21.31 Lakh (EBITDA margin 7.6%). Revenue has grown at a compounded annual rate (CAGR) of 167% over three years.
The company is associated with 1 brand: Cure Plus Biosciences. As per MCA filings, the company has open charges of ₹14 Lakh on record.
Cure Plus Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0173230). For more details, the company can be reached via its website cureplus.in.
Company details
CIN U51909PN2020PTC191589
Registration Number 191589
Incorporation Date 30 June 2020
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0173230
Recognitions & Rankings of Cure Plus Biosciences
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0173230
Contact details
Cure Plus Biosciences Private Limited's registered office is in Pune, Maharashtra. Its website is cureplus.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. B – 1004 Balaji Mesmero Sr.No – 283/3 4/2/A Porwal Road Lohegaon, Pune, Maharashtra, India – 411047
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Cure Plus Biosciences Private Limited, buy the company report.
Comprehensive company report
Cure Plus Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cure Plus Biosciences operates one associated brand: Cure Plus Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Healthcare products and services in biologics, orthopedics, and pain management in Pune, India. | cureplus.in |
Business activity
The main business activity of Cure Plus Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cure Plus Biosciences Private Limited, buy the company report.
Financials of Cure Plus Biosciences Private Limited
FY 2025 filings availableCure Plus Biosciences Private Limited reported revenue of ₹2.79 Cr (up 67% YoY) for FY 2024.
Revenue · FY 2024
₹2.79 Cr ▲ 67%
Net profit · FY 2024
₹6.83 Lakh margin 2.4%
EBITDA · FY 2024
₹21.31 Lakh margin 7.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 167%
EBITDA CAGR growth
1 year
▲ 58%
3 years · compounded
▲ 214%
Revenue has grown at a compounded annual rate (CAGR) of 167% over three years, including 67% growth in the latest year. EBITDA rose 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹21.31 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹6.83 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.6% | |||
| Net Profit Margin | 2.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Cure Plus Biosciences Private Limited, buy the company report.
Board of directors of Cure Plus Biosciences Private Limited
Cure Plus Biosciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sulbha Laxman Hingane | Director | 31 Oct 2023 | 2 Years 11 Months | Current |
| Chetan Purushotam Wadgure Also directs: Regenerexx Biologics Private Limited | Director | 30 Jun 2020 | 6 Years 3 Months | Current |
Auditor
Cure Plus Biosciences Private Limited is audited by B P S D & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B P S D & ASSOCIATES | FY 2023 | 118251W |
Shareholding
The shareholding of Cure Plus Biosciences Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cure Plus Biosciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹14 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jan 2024 | 100873232 | Others | ₹14 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cure Plus Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cure Plus Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cure Plus Biosciences Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Cure Plus Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cure Plus Biosciences Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Sulbha Laxman Hingane was appointed as Director on 31 Oct 2023.
AGM
Cure Plus Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cure Plus Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Charges
A charge with Others amounted to Rs. 14.00 Lakh with Charge ID 100873232 was registered on 16 Jan 2024.
Appointed
Sulbha Laxman Hingane was appointed as Director.
Ceased
Sultan Singh Bist ceased to be Director.
Appointed
Chetan Purushotam Wadgure was appointed as Director.
Incorporation
30 Jun 2020
Cure Plus Biosciences Private Limited was registered on 30 Jun 2020 with Roc Pune & aged 6 years 3 months as per MCA records.
Frequently asked questions
Cure Plus Biosciences is an active private limited company based in Pune, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 30 June 2020 (6+ years old) and is registered under CIN U51909PN2020PTC191589.
Cure Plus Biosciences has 2 current directors:
- Sulbha Laxman Hingane - Director
- Chetan Purushotam Wadgure - Director
The latest financial statements of Cure Plus Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Cure Plus Biosciences is U51909PN2020PTC191589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cure Plus Biosciences was incorporated on 30 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
Sulbha Laxman Hingane was appointed as Director on 31 Oct 2023. Sultan Singh Bist ceased to be Director on 31 Oct 2023. Chetan Purushotam Wadgure was appointed as Director on 30 Jun 2020.
Yes, Cure Plus Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Cure Plus Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0173230).
Cure Plus Biosciences can be reached through the website cureplus.in. Its registered office is in Pune, Maharashtra, India.
The registered office of Cure Plus Biosciences is at Flat No. B – 1004 Balaji Mesmero Sr.No – 2833 42A Porwal Road Lohegaon, Pune, Maharashtra, India – 411047.